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Abstract 
Background: Chronic post-lobectomy empyema is rare but may require space obliteration for infection contrai. 
We report our experience by using a tailored thoracomyoplasty for this specific indication with respect to 
infection contrai and functional outcome. 
Patients and Methods: We retrospectively analysed 17 patients ( 11 men, 6 women) with chronic post-lobectomy 
empyema and treated by thoracomyoplasty in our institution between 2000 and 2011. Ali patients underwent an 
initial treatment attempt by use of chest tube drainage and antibiotics except those with suspicion of pleural 
aspergillosis (n=6). In 5 patients, branchus stump insufficiency was identified at preoperative bronchoscopy. A 
tailored thoracoplasty was combined with a serratus anterior - rhomboid myoplasty which also served to close a 
broncho-pleural fistula, ifpresent. The first rib was resected in 11/17 patients. 
Resu!ts: The 90-day mortality was 11.7%. Thoracomyoplasty was successful in ail surviving patients with 
respect to infection contrai, space obliteration and definitive closure of broncho-pleural fistula, irrespective of 
the type of infection, the presence of a broncho-pleural fistula and whether a 1 '1 rib resection was performed . 
Post-lobectomy pulmonary function testing before and after thoracoplasty revealed a mean predicted FEY l of 
63.0±8.5% and 51.5±4.2% (p=0.01), and a mean predicted DLCO of59.8±11.6% and 54.5±12.5%, respectively. 
Postoperative shoulder girdle dysfunction and scoliosis were prevented in patients willing to undergo intense 
physiotherapy. 
Conclusions: Tailored thoracomyoplasty represents a valid option for patients with chronic post-lobectomy 
empyema without requiring a preceding open window thoracostomy. Space obliteration and infection contrai 
was equally obtained with and without first rib resection. 
Abstract word count: 250 
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Abstract 
Background: Chronic post-lobectomy empyema is rare but may require space obliteration for infection contrai. 
We report our experience by using a tailored thoracomyoplasty for this specific indication with respect to 
infection contrai and functional outcome. 
Patients and Methods: We retrospectively analysed 17 patients (11 men, 6 women) with chronic post-lobectomy 
empyema and treated by thoracomyoplasty in our institution between 2000 and 2011. Ali patients underwent an 
initial treatment attempt by use of chest tube drainage and antibiotics except those with suspicion of pleural 
aspergillosis (n=6). ln 5 patients, branchus stump insufficiency was identified at preoperative bronchoscopy. A 
tailored thoracoplasty was combined with a serratus anterior - rhomboid myoplasty which also served to close a 
broncho-pleural fistula, ifpresent. The first rib was resected in 11/17 patients. 
Results: The 90-day mortality was 11.7%. Thoracomyoplasty was successful in ail surviving patients with 
respect to infection contrai, space obliteration and definitive closure of broncho-pleural fistula, irrespective of 
the type of infection, the presence of a broncho-pleural fistula and whether a 1 '1 rib resection was performed . 
Post-lobectomy pulmonary function testing before and after thoracoplasty revealed a mean predicted FEVI of 
63.0±8.5% and 51.5±4.2% (p=0.01), and a mean predicted DLCO of59.8±11.6% and 54.5±12.5%, respectively. 
Postoperative shoulder girdle dysfunction and scoliosis were prevented in patients willing to undergo intense 
physiotherapy. 
Conclusions: Tailored thoracomyoplasty represents a valid option for patients with chronic post-lobectomy 
empyema without requiring a preceding open window thoracostomy. Space obliteration and infection contrai 
was equally obtained with and without first rib resection. 
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Introduction 
The incidence of a residual pleural space after lobectomy ranges from 5-21 % at discharge after removal of the 
chest tubes [1-4]. In more than 95% of the patients, it resoives without further treatment during follow up; 
compiete regression was observed in 9I% of patients within one year after operation [3). However, in 2% of the 
patients, infection will subsequently develop within a residual post-lobectomy space [1-3,5]. Prolonged air leak 
(> 7 days) and chest tube drainage, branchus stump insufficiency with broncho-pleural fistula, age, previous 
chemotherapy or irradiation and associated co-morbidity are ail implicated in the development of a post-
lobectomy empyema which is mainiy observed after upper lobectomy [3]. Proionged air leak and chest tube 
drainage are present in 10% of patients after lobectomy and are the main causes of contamination and infection 
of a residual pleural space after Jung resection whereas branchus stump insufficiency and broncho-pleural fistula 
are relatively rare after lobectomy. ln the presence of a broncho-pleural fistula, the infected pleural space will 
continuously contaminate the remaining Jung leading to repeated pneumonia and destruction of the remnant 
Jung. Microbiological assessment of chronically infected post-lobectomy spaces usually reveals polymicrobial or 
fungal colonialization [6]. 
The management ofinfected post-resectional residual spaces after lobectomy remains challenging [6,7). 
As for parapneumonic empyema, the goal of treatment relies in the re-expansion of the remnant Jung leading to 
the obliteration of the infected space [8,9). This may be obtained by antibiotics, CT-guided pigtail drainage and 
fibrinolytic instillation in the early phase of infection. However, in case of chronic infections, the Jung is trapped 
as seen in chronic empyema. In this situation, open decortication is Jess likely to be successful compared to 
parapneumonic empyema since the trapped remaining Jung might fail to fill the chest cavity, even after 
decortication. This holds especially true in the presence of a broncho-pleural fistula or the colonization of the 
residual cavity by multi-resistant germs or Aspergillus fi1111igat11s where complete space obliteration is of 
paramount importance to achieve permanent contrai of infection. ln case of a chronic post-resection empyema 
open window thoracostomy [ 1 O] may therefore be required with packing of the cavity or treatment by vacuum 
assisted wound management' 1 followed by space obliteration either by intrathoracic omentum [ 12] of muscle 
transfer [13-15] or tailored thoracoplasty [16-20] or a combination ofboth (thoracomyoplasty) [21,22). Although 
there is some recrudescence in the recent literature for thoracomyoplasty and its raie in the modern thoracic 
surgery armamentarium, very few reports focus on its specific use for the treatment of chronically infected 
pleural spaces after lobectomy which are increasingly observed in our days in the context of neoadjuvant or 
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adjuvant radio-chemotherapy applied for locally advanced NSCLC, or after lobectomy performed in immuno-
deficient patients. This report analyses a one decade single institution experience using thoracomyoplasty for the 
treatment of post-Iobectomy empyema with respect to postoperative mortality, morbidity, contrai of infection 
and functional outcome, including pulmonary fonction testing, scoliosis and shoulder girdle mobility. 
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Material and Methods 
We retrospectively reviewed ail patients undergoing thoracomyoplasty for a chronically infected pleural space 
after lobectomy in our institution between 2000 and 201 O. The study was reviewed and approved by the 
Institutional Ethical Committee and individual patient consent was waived. 
Clinical ll'ork-up: Ali patients underwent clinical, cardiopulmonary, nutritional and radiological work up prior to 
operation. CT-guided pigtail drainage followed by microbiological analysis was performed in ail patients 
without suspicion of aspergillosis as well as bronchoscopy in order to assess the presence or absence of a 
bronchus stump insufficiency or a broncho-pleural fistula, Aspergillosis was suspected on the base of typical 
signs on CT imaging (fungus ball) or in the presence of Aspergillus precipitin. Thoracomyoplasty was then 
performed without an attempt of drainage. Thoracomyoplasty was performed if a chronically infected residual 
pleural space failed to resolve with a one week regimen of antibiotics, pigtail drainage and fibrinolytic 
instillation. This time frame was also used to assess cardiopulmonary reserves and to optimize the nutritional 
status. An open window thoracostomy preceding the thoracomyoplasty was not performed in any patient. 
Technique of limited thoracomyoplasty: Epidural thoracic anesthesia was installed prior to general anesthesia 
and endotracheal intubation. The incision was performed at the level of the initial posterolateral incision and 
prolonged cranially if necessary. The latissimus dorsi muscle was divided at its initial site of division and the 
serratus anterior and the rhomboid muscles were preserved, including their chest wall insertion. The ribs !-VII 
were exposed. An extramusculoperiosteal tailored thoracoplasty was performed as described by Alexander. The 
extent of rib resection was determined by the extent of the residual cavity and included one rib below the most 
inferior part of disease. A sloping resection of the anterior part of the ribs was performed with progressively Jess 
resection for more caudal located ribs. Posteriorly, the ribs were disarticulated at the level of the costo-
transversal and costo-vertebral ligament but the transverse processes were preserved. The 1 '1 rib was resected in 
11/17 patients but an extrafacial apicolysis was routinely performed. 
The residual cavity was accessed between two intercostals muscles and was debrided by dissecting the 
inflammatory peel overlying the lung but only at the level of the infected pleural space. The same procedure was 
applied for ail types of infection including Aspergil111sf11111igat11s colonialization (Figure 1 ). 
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The serratus anterior and the rhomboideus muscles were detached en bloc from their insertion on the 
undersurface of the scapula while keeping their chest wall insertion intact (Figure 2). This allowed the coverage 
of the underlying lung and intercostal muscle layer by an additional well-vascularized muscle layer. A broncho-
pleural fistula, if present, was closed by suturing the serratus muscle into the debrided bronchial stump by use of 
interrupted 4-0 Prolene® stitches as previously described without attempting a primary bronchus stump closure 
[23,24]. The tip of the scapula was resected in order to avoid impingement with the remaining ribs. One chest 
tube was inserted between the scapula and the muscle layers. The soft-tissue closure was performed in two layers 
(latissimus dorsi and skin). The chest tubes were removed in the absence of air leaks and excessive of liquid 
drainage ( <150 ml/24h) (Figure 3). Early postoperative physiotherapy-assisted shoulder girdle mobilization was 
prescribed to prevent a frozen shoulder. In patients with pleural or invasive aspergillosis, Voriconazole (V fend®) 
was prescribed for a period of3 months. 
Folloll'-11p: The postoperative course was evaluated with respect to 90-day mortality, morbidity, wound healing, 
control of infection and space obliteration and hospital stay. After discharge, ail surviving patients were regularly 
followed in the outpatient clinic on a clinical and radiological base with respect to pain control, wound healing, 
shoulder girdle function and control of infection. Pulmonary function testing was performed 3 months after the 
operation. The student's t-test for paired observation was used for statistical analysis where appropriate and 
significance was accepted at p < 0.05 using a bidirectional hypothesis. 
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Results 
Seventeen patients underwent tailored thoracomyoplasty for chronically infected residual pleural spaces after 
Iobectomy between 2000 and 2010 at our institution. There were 11 men and 6 women with a mean age of 63 
(range 40-77) years. Ali patients presented with additional comorbidity including coronary artery disease (n=5), 
chronic renal failure (n=3), stage IV COPD (n=5), diabetes (n=2) and steroid medication (n=2). The indication 
for lobectomy was non-small cell Jung cancer (n=9), Jung abscess (n=4), bronchiectasis (n=2), heterogeneous 
emphysema with upper lobe predominance (n=l) and aspergilloma in a sarcoidosis-induced Jung excavation 
(n=I). The intervention was right- and left sided in 10 and 7 patients, respectively. Six patients with stage III 
NSCLC received neoadjuvant radio-chemotherapy and 3 with stage II NSCL had adjuvant chemotherapy. Ali 
patients underwent initial Iobectomy by a posterolateral thoracotomy with division of the Iatissimus dorsi but 
preservation of the serratus anterior muscle. 
The time interval between lobectomy and clinical appearance of residual pleural space infection ranged from 28 
days to 4 years (median 40 days). Eleven patients (65%) presented with infection within 3 months after 
lobectomy. The microbiological analysis of the infected pleural space revealed methicillin-resistant 
Staphy!ococcus aureus (n=3), Steptococcus pneu mania (n=2), Enterococcus (n=I ), Pseudomonas (n=l) and 
polymicrobial infection (n=l). No germs were identified in two patients. Seven patients presented coionialisation 
of the pleural space by Aspergillus fi1111igat11s (table 1) and three of these patients had radiological signs of 
chronic radiation pneumonitis. Broncho-pleural fistulas were diagnoses in five patients by pre-operative 
bronchoscopy. 
Thoracomyoplasty was performed as a one stage procedure in all patients and a median of five (range 4 to 8) ribs 
were removed. The first rib was resected in 11 patients (65%). Ali patients underwent serratus-rhomboideus 
muscle transposition which was used to close a broncho-pleural fistula in five patients. 
The 90-days postoperative mortality (2/17) was 11. 7%. One patient <lied 10 days postoperatively of anoxie brain 
damage which occurred in the context of massive aspergillosis-related haemoptysis requiring cardiopulmonary 
reanimation and unsuccessful embolisation three days before thoracoplasty. However, there was no recurrence of 
hemoptysis in the postoperative phase in this patient. Another patient <lied 40 days postoperatively from 
contralateral pneumonia and rapidly progressing malignant disease. In both patients, a decline of aggressive 
treatment and installation ofTLC was realized due in the context of an incurable situation. 
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The postoperative morbidity (9/17) was 52%. Two patients required a re-intervention in the early postoperative 
phase, one for bleeding and one for closure of a persistent broncho-pleural fistula with by the debrided branchial 
muscle layer. Nine patients developed a postoperative pneumonia, 2 of them required non-invasive ventilation 
and 2 a temporary tracheostomy mainly related to preoperative compromised pulmonary functions. One patient 
developed in addition a Clostridum difficile colitis. The median ICU and hospital stay were 2 (range 0-33) days 
and 23 (range 11-90) days, respectively. 
Contra! of pleural space infection: Follow-up was obtained in ail surviving 15 patients with a mean follow up 
time of 15 (range 3-1 OO) months. Seven patients <lied of progressive tumor disease within the first two years and 
one patient of AIDS 5 years after thoracoplasty. Thoracomyoplasty was successful in al! patients with respect to 
infection contrai, space obliteration and definitive clos ure of broncho-pleural fistula, irrespective of whether the 
1 si rib was removed or not. Referring to their operation, al! but one patients claimed to experience a life without 
restriction in their daily activities during follow-up. 
Shoulder girdle fi111ctio11 and cervical scoliosis: Prolonged (> 3 months) opioid-based analgesic medication and 
intense physiotherapy-assisted shoulder girdle mobilization was required in al! patient to prevent a frozen 
shoulder. After 3 months, abduction of the involved arm ranged between 170° and 80° (Figure 4). The same 
holds true for patients with 1 si rib resection. Despite intense physiotherapy, scoliosis of 30° towards the operated 
side was observed in the majority of patients with 1 si rib resection. In contrast, scoliosis deformities were not 
observed in patients without 1 si rib resection. In general, daily activity and quality of life was substantially 
impaired by thoracoplasty. 
PulmonaJJ' fimction testing: ln 7 patients, post-lobectomy pulmonary function testing was available before and 
after thoracomyoplasty. Pulmonary function testing before and after thoracoplasty revealed a mean predicted 
FEY! of 63.0 ± 8.5% and 51.5 ± 4.2% and a mean predicted DLCO of 59.8 ± 11.6% and 54.5 ± 12.5%, 
respectively. The difference was statistically significant for FEY 1 (p=O.O 1) but not for DLCO. 
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Discussion 
Thoracoplasty in combination with muscle tlap transposition has been applied successfully to achieve pleural 
space obliteration in patients presenting chronic post-lobectomy empyema [ 10, 17-22]. This complex 
pathological entity is increasingly observed in the context of pulmonary resections performed after radio-
chemotherapy or resections realized in immune-deftcient patients. In these situations, the pleural space usually 
contains polymicrobial infections including multi-resistant germs or aspergillus fumigatus [ 16, 18, 19] which 
requires efficient space obliteration with healthy vascularized tissues in order to obtain permanent infection 
control. 
In our series, we reported on 17 patients with chronically infected pleural spaces after lobectomy treated 
by thoracomyoplasty over the last decade. Ali of them had additional and multiple co-morbidities such as 
coronary artery disease, chronic renal failure, advanced COPD, diabetes or steroid medication which might have 
contributed to impaired immunity. This may in part explain the rather high 90-day postoperative mortality and 
morbidity in our series. Indeed, the two postoperative deaths in our series were merely related to progressive 
decline of treatment delivery due to an incurable underlying process (anoxie brain damage after previously 
performed unsuccessful embolisation for massive hemotpysis; tumor progression) than to the procedure itself. 
Conversely, thoracomyoplasty was successful in ail surviving patients with respect to infection control, space 
obliteration and deftnitive clos ure of broncho-pleural ftstulas. 
The majority of patients underwent lobectomy for lung cancer with either neoadjuvant or adjuvant 
radio-chemotherapy, three with radiological signs of chronic radiation pneumonitis. ln the majority of patients, 
the infected pleural space revealed multi-resistant germs or aspergillus f11111igatus and 30% of the patients 
presented with a broncho-pleural ftstula. Ali patients were treated by a one-stage tailored Alexander 
thoracoplasty with extrafascial apicolysis; however, ftrst rib resection was progressively abandoned over time to 
decrease the risk of cervical scoliosis development. In addition to tailored thoracoplasty, the patients underwent a 
modifted serratus anterior-rhornboideus muscle tlap transposition for additional space obliteration. This 
maneuver allowed efficient space obliteration and the simultaneous closure of a broncho-pleural ftstula ifpresent 
as a one-stage procedure which rendered the realization of a preceding thoracic window unnecessary. A 
temporary thoracic window is usually performed in the initial phase of treatment for control of pleural infection 
followed by space obliteration by thoracoplasty or muscle tlaps in a second step [2,9,21]. Here we describe a 
modifted technique of myoplasty which consists of detaching the serratus anterior and rhomboideus muscle 
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layers en bloc from the scapula without disinsertion of the muscles from the chest wall. This allowed for the 
coverage of the entire underlying lung and efficient obliteration of the residual cavity but required the resection 
of the tip of the scapula in order to avoid impingement of the scapula at the level of the remaining ribs. In case of 
broncho-pleural fistula, the debrided branchial stump was closed by suturing the muscle directly into the defect 
without attempting a primary branchial stump repair [23.24]. The advantages of transposed serratus anterior-
rhomboideus muscle tlaps over other vascularized tissues such as omentum [12] or pectoralis mayor muscles 
[25] are their large size, their mechanical strength and their proximity of the usually apically localized residual 
spaces [14] which renders them easily accessible through the same incision used to perform thoracoplasty. 
Others authors have described omentum [12] or pectoralis major tlaps [25] for space obliteration but these 
techniques require additional dissections on remote sites and were judged unnecessary in the presence of serratus 
anterior-rhomboideus tlaps which efficiently obliterated the residual spaces after lobectomy in our patients. 
Two recent studies assessed thoracoplasty in the context of post-lobectomy empyema. Stefani et al [20] 
reported on 19 patients who underwent an open window thoracostomy and thoracoplasty was only considered in 
those eight patients where thoracic window failed. Permanent infection contrai was obtained in 6/8 patients 
(75%) after thoracoplasty. Krassas et al [22] reported on 8 patients who underwent apical thoracoplasty for post-
lobectomy empyema. Aspergillus fumigatus was present in 6 patients; three of these patients (50%) revealed 
radiation pneumonitis in their remaining lung. Ali 8 patients had permanent contrai of infection in the obliterated 
pleural cavity. ln both series, the authors observed a progressively increased association of extrathoracic muscle 
tlap transposition to thoracoplasty over time in patients with broncho-pleural fistulas, large spaces or insufficient 
collapse after thoracoplasty alone [20,22]. 
Regarding the functional aspects of thoracomyoplasty in our series, tailored thoracoplasty combined 
with serratus anterior-rhomboideus myoplasty resulted in a significant loss ofFEVI (L'l 12% predicted) but not of 
DLCO. Postoperative shoulder girdle function could be restored but required intensive and long-lasting 
physiotherapy-assisted shoulder girdle mobilization. Recently, Botianu et al. reported on 76 patients who 
underwent thoracoplasty in association with muscular tlap transposition for chronic intrathoracic infections of 
various etiologies [13]. Jmpaired shoulder function was observed in 5/76 patients (6.6%) during follow-up and 
pulmonary functions were not significantly different before and after thoracoplasty. A concern remains the 
cosmetical aspects of thoracoplasty which were in general reasonably well accepted, probably due to the limited 
number ofribs resected. This observation was also confirmed by others authors [18,20]. 
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In conclusion, one-stage tailored thoracoplasty associated with serratus anterior-rhomboideus myoplasty 
is a useful technique of last resort for patients with chronically infected residual spaces after lobectomy. It 
affords optimal space obliteration and control of infection even in the presence of a broncho-pleural fistula 
without the need of open window thoracostomy or first rib resection. 
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Table 1. Patient's characteristics of one-stage tailored thoracomyoplasty for chronically infected residual pleural 
spaces after lobectomy 
Sex Age Cause of lobectomy Pleural microbiology Time interval 1 Resected ribs 
(days) 
M 64 Abscess LUL3 Aspergillus 360 
M 46 Abscess LUL polymicrobiaI 30 
M 61 NSCLC LUL negative 60 
M 63 NSCLC RUL negative 28 
M 69 LVRS4 RUL Streptococcus 30 
M 68 NSCLC LUL Staphylococcus MRSA 90 
F 76 NSCLC LUL Streptococcus 40 
M 51 Bronchiectasis LUL Staphylococcus MRSA 30 
M 40 Sarcoidosis LUL Aspergillus 40 
M 69 NSCLC RUL Ente roc accus 30 
M 77 Bronchiectasis RUL Aspergillus 28 
F 53 Bronchiectasis LUL Aspergillus 1440 
F 69 Abscess LUL Aspergillus 1445 
M 74 NSCLC RUL Staphylococcus MRSA 46 
M 61 NSCLC RUL Pseudomonas 1080 
F 67 NSCLC RUL+ML Aspergillus 1448 
F 59 NSCLC RUL+ML Aspergillus 730 
1 Time interval between lobectomy and clinical appearance of empyema 
2 Length of hospitalization after thoracomyoplasty 
3 LUL: left upper lobe, RUL: right upper lobe, ML: middle lobe 
4 Lung volume reduction surgery 
(11111nbe1) 
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Il-IV 
II-V 
1-IV 
I-IV 
!-IV 
I-IV 
!-VII 
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15 
25 
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24 
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21 
15 
Legend 
Figure 1: a) Chest CT scan showing an apical residual space after lobectomy with suspicion of pleural 
aspergillosis; b), intraoperative view confirming the presence of Aspergi!/11sf11111igat11s. 
Figure 2: Schematic drawing showing a), the extent of tailored thoracoplasty and b), the modified serratus 
anterior (SA) - rhomboideus (RHO) myoplasty with detachment ofboth muscles from the scapula while leaving 
their chest wall insertion intact. The tip of the scapula is resected in order to prevent impingement of the scapula 
with the remaining ribs. 
Figure 3: a) preoperative chest radiography of a chronically infected residual space which failed to respond to 
chest tube drainage and antibiotics; b) postoperative radiography after limited thoracomyoplasty. 
Figure 4: Shoulder girdle mobility with posterior and anterior view, one year after a tailored thoracomyoplasty 
and resection of the tip of the scapula. 
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